Initial Statement of Beneficial Ownership (3)
December 23 2019 - 1:02PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
|
1. Name and Address of Reporting Person
*
Foat Timothy G |
2. Date of Event Requiring Statement (MM/DD/YYYY)
10/11/2019
|
3. Issuer Name and Ticker or Trading Symbol
Bio-Matrix Scientific Group, Inc. [BMSN]
|
|
(Last)
(First)
(Middle)
1204 TANGERINE ST |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
Chief Executive Officer / |
|
(Street)
EL CAJON, CA 92021-5011
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4) | 2. Amount of Securities Beneficially Owned
(Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) | 4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Common Stock | 12500000 | I | Trustee Sherman Family Trust |
| Common Stock | 792500 | I | Trustee Bio-Technology Partners Business Trust |
| Common Stock | 3020143 | I | President Dunhill Ross Partners, Inc (1) |
| Common Stock | 437143 | I | President BioScientific Consultants |
| Common Stock | 3757 | I | President Sunset Cliffs Compliance |
| Preferred Stock | 1068 | I | President BioScientific Consultants |
| Preferred Stock | 2300 | I | Trustee Bio-Technology Partners Business Trust |
| Preferred Stock | 1187 | I | President Dunhill Ross Partners (1) |
| Preferred Series B Stock | 2678 | I | President BioScientific Consultants |
| Preferred Series B Stock | 179 | I | Trustee Bio-Technology Partners Business Trust |
| Preferred Series B Stock | 2041 | I | President Dunhill Ross Partners (1) |
| Preferred Series B Stock | 75 | I | President Sunset Cliffs Compliance |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4) | 2. Date Exercisable and Expiration Date
(MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) | 6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
| Explanation of Responses: |
| (1) | Formerly Venture Bridge Advisors, Inc |
Remarks:
On May 23,2013 Venture Bridge Advisors, Inc (a Nevada Corporation) changes its name to Dunhill Ross Partners, Inc (A Nevada Corporation). The stock in Venture Bridge Advisors name predates this name change and has not been reissued. |
Reporting Owners
|
| Reporting Owner Name / Address | Relationships |
| Director | 10% Owner | Officer | Other |
Foat Timothy G
1204 TANGERINE ST
EL CAJON, CA 92021-5011 |
|
| Chief Executive Officer |
|
Signatures
|
| Timothy G Foat | | 12/23/2019 |
| **Signature of Reporting Person | Date |